An observational prospective study of switching asthma patients from a fixed-dose combination (FDC) Inhaled Corticosteroids [ICS] / Long-Acting Beta-Agonists [LABA] therapy delivered by pMDI Seretide® Evohaler to ICS/LABA delivered by pMDI Flutiform® Read more about An observational prospective study of switching asthma patients from a fixed-dose combination (FDC) Inhaled Corticosteroids [ICS] / Long-Acting Beta-Agonists [LABA] therapy delivered by pMDI Seretide® Evohaler to ICS/LABA delivered by pMDI Flutiform®
An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of BetazoleTM Cream Containing Betamethasone dipropionate (0.05% W/W) and Miconazole nitrate (2% W/W) in Subjects with Inflamed Skin Conditions of Eczema or Dermatitis 2ry Caused by Infection With Fungi Read more about An open label, Phase IV Multicentric Single Arm Study to Assess the Safety and Efficacy of BetazoleTM Cream Containing Betamethasone dipropionate (0.05% W/W) and Miconazole nitrate (2% W/W) in Subjects with Inflamed Skin Conditions of Eczema or Dermatitis 2ry Caused by Infection With Fungi
An open label, Phase IV, multicenter study to Assess the efficacy and safety of Elica-MTM Cream Containing Miconazole nitrate 2% w/w and Mometasone furoate 0.1% w/w) in Napkin Dermatitis with Inflamed Skin Conditions of Eczema or Dermatitis Caused by Infection With Certain Fungi and Bacteria Read more about An open label, Phase IV, multicenter study to Assess the efficacy and safety of Elica-MTM Cream Containing Miconazole nitrate 2% w/w and Mometasone furoate 0.1% w/w) in Napkin Dermatitis with Inflamed Skin Conditions of Eczema or Dermatitis Caused by Infection With Certain Fungi and Bacteria
UPDATES: A prospective non-interventional study investigating the treatment effect of Tresiba® in adult patients with type 2 diabetes in Saudi Arabia Read more about UPDATES: A prospective non-interventional study investigating the treatment effect of Tresiba® in adult patients with type 2 diabetes in Saudi Arabia
Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhibitors in Saudi Arabia Read more about Post-authorization safety study in patients with type 2 diabetes mellitus to assess the incidence of ketoacidosis, severe complications of urinary tract infection, volume depletion, and dehydration among patients treated with EMPAGLIFLOZIN or DPP-4 inhibitors in Saudi Arabia
MultiZonal obsERvational study conducted By clinIcal practitioners on Repatha® use iN subjects with hyperlipIdemia - ZERBINI Read more about MultiZonal obsERvational study conducted By clinIcal practitioners on Repatha® use iN subjects with hyperlipIdemia - ZERBINI
A single-arm interventional Phase IV, post-authorisationstudy evaluating the safety of pediatric patients withtransfusional hemosiderosis treated with deferasiroxcrushed film coated tablets Read more about A single-arm interventional Phase IV, post-authorisationstudy evaluating the safety of pediatric patients withtransfusional hemosiderosis treated with deferasiroxcrushed film coated tablets
AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting. Read more about AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting.
"AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting." Read more about "AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting."
Apixaban in Patients with Left Ventricular Thrombus, CLEAN-LV Study Read more about Apixaban in Patients with Left Ventricular Thrombus, CLEAN-LV Study
